Fighting Ovarian Cancer: The Search For Better Outcomes

Contrary to popular belief, ovarian cancer is actually not a silent killer. There are certain indicators; it’s just that the way they manifest is usually mistaken for something else. As a result of this, the disease continues to take the lives of around 15,000 women each year in the United States, most of whom are diagnosed at a late stage.

Despite this fact, we can still be hopeful of the future. The latest progress in therapy has introduced us with three new drugs named PARP inhibitors. These are especially effective for those with inherited BRCA1 or BRCA2 mutations, which is responsible …read more